Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.
Open Forum Infect Dis
; 1(3): ofu102, 2014 Dec.
Article
in En
| MEDLINE
| ID: mdl-25734170
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Open Forum Infect Dis
Year:
2014
Type:
Article